Plasmodium ovale

Plasmodium ovale is a protozoan parasite and one of the species of Plasmodium that cause malaria in humans. It is one of the five species of Plasmodium that commonly infect humans, the others being Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium knowlesi.
Morphology[edit]

Plasmodium ovale is characterized by its oval-shaped infected red blood cells, which are slightly larger than uninfected cells and have a fimbriated edge. The presence of Schüffner's dots and hemozoin pigment is also a distinguishing feature. The parasite undergoes a complex life cycle involving both asexual and sexual stages.
Life Cycle[edit]
The life cycle of Plasmodium ovale involves two hosts: the human host and the Anopheles mosquito. In humans, the parasite undergoes asexual reproduction in the liver and red blood cells. The sexual stage occurs in the mosquito, where the parasite undergoes fertilization and development into sporozoites, which are then transmitted back to humans through a mosquito bite.
Epidemiology[edit]

Plasmodium ovale is primarily found in sub-Saharan Africa, but it can also be found in parts of Asia and the Western Pacific. It is less common than Plasmodium falciparum and Plasmodium vivax. The incidence of Plasmodium ovale is often underestimated due to its similarity to Plasmodium vivax and the lack of specific diagnostic tools.
Clinical Features[edit]
Infection with Plasmodium ovale causes a form of malaria that is generally less severe than that caused by Plasmodium falciparum. Symptoms include fever, chills, headache, and muscle aches. The disease can cause relapses due to dormant liver stages known as hypnozoites.
Diagnosis and Treatment[edit]
Diagnosis of Plasmodium ovale infection is typically made by microscopic examination of blood smears stained with Giemsa. Molecular methods such as PCR can also be used for more accurate diagnosis. Treatment involves the use of antimalarial drugs such as chloroquine and primaquine, the latter being used to eliminate hypnozoites and prevent relapses.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian